Gianluigi Forloni

Head

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gianluigi Forloni is the Head of the Istituto di Ricerche Farmacologiche Mario Negri IRCCS in Italy. His research focuses on Alzheimer's disease, synucleinopathies, prion diseases, and the effects of neonicotinoid pesticides on neural development. He has contributed to the understanding of the biological mechanisms underlying treatment efficacy in depression and the role of dietary factors in frailty.

Articles (8)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Brian Appleby

Case Western Reserve University

UNITED STATES

View details

Inga Zerr

GERMANY

View details

Anna ladogana

Head of research

Istituto Superiore di Sanità

ITALY

View details

Daniel Souery

Head

BELGIUM

View details

DIEGO ALBANI

UNIT HEAD

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gianluigi Forloni

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Doxycycline: An essential tool for Alzheimer’s disease

Neonicotinoid Pesticides Affect Developing Neurons in Experimental Mouse Models and in Human Induced Pluripotent Stem Cell (iPSC)-Derived Neural Cultures and Organoids

Creutzfeldt–Jakob disease and other prion diseases

Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model

Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression

Plasmatic Hippuric Acid as a Hallmark of Frailty in an Italian Cohort: The Mediation Effect of Fruit–Vegetable Intake

A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages

Alzheimer’s disease: from basic science to precision medicine approach

Collaborators (5)

Brian Appleby

Inga Zerr

Anna ladogana

Daniel Souery

DIEGO ALBANI

Make your next move.